Literature DB >> 7801792

The role of dopamine in the regulation of melatonin biosynthesis in vertebrate retina.

J B Zawilska1.   

Abstract

The vertebrate retina rhythmically synthesizes melatonin, a hormone involved in the regulation of several intraocular processes cued by environmental lighting conditions. The rhythm of retinal melatonin production, with maximal synthesis at night in darkness, is driven by the photoperiodic environment to which animals are exposed, and is generated by an endogenous circadian clock(s). This article reviews data on the role of dopamine, an established retinal neurotransmitter and paracrine factor, as a mediator of acute suppressive and entrainment action of light on the melatonin generating system in the retina. Special emphasis is given to the characterization of dopamine receptor types involved in the control of retinal melatonin formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7801792

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  3 in total

1.  Circadian variation in the electroretinogram and the presence of central melatonin.

Authors:  J Lavoie; A-M Gagné; M-P Lavoie; A Sasseville; M-C Charron; M Hébert
Journal:  Doc Ophthalmol       Date:  2010-02-11       Impact factor: 2.379

2.  Effects of Melatonin on Dairy Herd Improvement (DHI) of Holstein Cow with High SCS.

Authors:  Hao Wu; Songyang Yao; Tiankun Wang; Jun Wang; Kang Ren; Hai Yang; Wenkui Ma; Pengyun Ji; Yongqiang Lu; Hui Ma; Changwang He; Wenjuan Wei; Lu Zhang; Guoshi Liu
Journal:  Molecules       Date:  2021-02-05       Impact factor: 4.411

3.  Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?

Authors:  Michele Fornaro; Fabio Bandini; Luca Cestari; Christian Cordano; Carla Ogliastro; Claudio Albano; Domenico De Berardis; Matteo Martino; Andrea Escelsior; Giulio Rocchi; Pantaleo Fornaro; Concetta De Pasquale
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-20       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.